Polymegathism as a biomarker of mitochondrial disorders.

Graefes Arch Clin Exp Ophthalmol

University of Tunis El Manar and Genomics Platform, Pasteur Institute of Tunis, Tunis, Tunisia.

Published: June 2018

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00417-018-3960-6DOI Listing

Publication Analysis

Top Keywords

polymegathism biomarker
4
biomarker mitochondrial
4
mitochondrial disorders
4
polymegathism
1
mitochondrial
1
disorders
1

Similar Publications

Mitochondrial A3243G mutation results in corneal endothelial polymegathism.

Graefes Arch Clin Exp Ophthalmol

March 2018

Jonas Children's Vision Care, and Bernard & Shirlee Brown Glaucoma Laboratory, Columbia University, New York, NY, USA.

Purpose: The mitochondrial DNA point mutation A3243G leads to a spectrum of syndromes ranging from MIDD to MELAS. Ocular manifestations include pattern macular dystrophy and concentric perifoveal atrophy. Given the high metabolic demand of corneal endothelial cells, we performed specular biomicroscopy analysis in patients harboring the mitochondrial DNA point mutation A3243G to assess for the associated presence of corneal endothelial abnormalities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!